Oliver Lagore Vanvalin Investment Group’s Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 CPUH.WS Stock Holding History
Bought
Maintained
Sold
Oliver Lagore Vanvalin Investment Group's CPUH.WS Position: Q3 2023 in Review
Oliver Lagore Vanvalin Investment Group sold out of Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (CPUH.WS) in Q3 2023, closing a stake of 100 shares — an estimated $50 sold.
Oliver Lagore Vanvalin Investment Group first reported a position in CPUH.WS in Q1 2022 and held it in 6 quarters. The position peaked at $50 in Q2 2023. 0 funds tracked by Wall St. Rank hold CPUH.WS as of Q3 2023.
- Oliver Lagore Vanvalin Investment Group reported no remaining Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q3 2023 after selling out during the quarter.
- Oliver Lagore Vanvalin Investment Group sold 100 Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q3 2023, an estimated $50.
- Oliver Lagore Vanvalin Investment Group first reported a position in Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q1 2022 and held it in 6 quarters.
- Oliver Lagore Vanvalin Investment Group's Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $50 in Q2 2023.
- 0 funds tracked by Wall St. Rank held Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q3 2023.
Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q3 2023, filed 9 Nov 2023.